ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Return
4.95%
This Quarter Return
+5.35%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$235M
AUM Growth
+$46.1M
(+24%)
Cap. Flow
+$35.5M
Cap. Flow
% of AUM
15.07%
Top 10 Holdings %
Top 10 Hldgs %
46.57%
Holding
91
New
39
Increased
11
Reduced
15
Closed
22
Top Buys
| 1 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
$12.4M |
| 2 |
Bristol-Myers Squibb
BMY
|
$11.5M |
| 3 |
Gilead Sciences
GILD
|
$10.1M |
| 4 |
Takeda Pharmaceutical
TAK
|
$8.91M |
| 5 |
Icon
ICLR
|
$8.16M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$14.8M |
| 2 |
CELG
Celgene Corp
CELG
|
$10.8M |
| 3 |
SHPG
Shire pic
SHPG
|
$8.02M |
| 4 |
CVS Health
CVS
|
$7.36M |
| 5 |
DaVita
DVA
|
$7.24M |
Sector Composition
| 1 | Healthcare | 79.87% |
| 2 | Technology | 11.14% |
| 3 | Industrials | 3.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Sanofi
SNY
$114B
| – | – |
-81,401
| Closed | -$3.53M |
|
77
SPDR S&P 500 ETF Trust
SPY
$663B
| – | – |
0
| – | – |
|
78
Stryker
SYK
$151B
| – | – |
-7,319
| Closed | -$1.15M |
|
79
Teva Pharmaceuticals
TEVA
$21.5B
| – | – |
-73,884
| Closed | -$1.14M |
|
80
UnitedHealth
UNH
$285B
| – | – |
-16,732
| Closed | -$4.17M |
|
81
Viatris
VTRS
$12.2B
| – | – |
-77,135
| Closed | -$2.11M |
|
82
Health Care Select Sector SPDR Fund
XLV
$34.1B
| – | – |
0
| – | – |
|
|
NVRO
83
DELISTED
NEVRO CORP.
NVRO
| – | – |
-54,977
| Closed | -$2.14M |
|
|
KA
84
DELISTED
Kineta, Inc. Common Stock
KA
| – | – |
0
| – | – |
|
|
MDRX
85
DELISTED
Veradigm Inc. Common Stock
MDRX
| – | – |
-591,533
| Closed | -$5.7M |
|
|
CELG
86
DELISTED
Celgene Corp
CELG
| – | – |
-168,609
| Closed | -$10.8M |
|
|
SHPG
87
DELISTED
Shire pic
SHPG
| – | – |
-46,100
| Closed | -$8.02M |
|
88
Standard BioTools
LAB
$500M
| – | – |
-236,648
| Closed | -$2.04M |
|
89
McKesson
MCK
$85.4B
| – | – |
-4,966
| Closed | -$549K |
|